Levetiracetam Alter

Levetiracetam, the active ingredient in Levetiracetam Alter, is an antiepileptic presented as an oral dosage form for oral use. It is employed to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy across the European market.

GNH USA supplies Levetiracetam Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability to prevent seizure activity.

Partial‑onset seizures: reduces the frequency and severity of focal seizures. Generalized tonic‑clonic seizures: helps achieve seizure freedom or significant reduction. Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nausea: upset stomach or feeling of queasiness. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or severe anxiety. - Blood disorders: low white blood cells or platelets. - Liver dysfunction: jaundice or abnormal liver enzymes. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures.

Renal function: dose may need adjustment in patients with impaired kidney function. Pregnancy: discuss potential risks with a healthcare professional. Concomitant CNS depressants: monitor for enhanced sedation. Behavioral changes: observe for mood swings or depression. Alcohol use: avoid excessive intake as it may increase dizziness. Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam concentrations. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Sedative antihistamines: can enhance drowsiness. - Opioids: monitor for additive respiratory depression. - Other antiepileptics: assess overall seizure control and side‑effect profile.